These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2869141

  • 1. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
    Nagahama S, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
    [Abstract] [Full Text] [Related]

  • 3. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S, Ann HS, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [Abstract] [Full Text] [Related]

  • 4. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF, Jin HK, Paul R, Nagahama S.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [Abstract] [Full Text] [Related]

  • 5. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
    Damase-Michel C, Montastruc JL, Gharib C, Geelen G, De Saint-Blanquat G, Tran MA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
    [Abstract] [Full Text] [Related]

  • 6. Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
    Igarashi Y, Chen YF, Wyss JM, Lindheimer MD, Oparil S.
    Pharmacology; 1987 Feb; 35(4):194-202. PubMed ID: 2959969
    [Abstract] [Full Text] [Related]

  • 7. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF, Oparil S.
    Brain Res; 1987 Jan 06; 400(2):225-31. PubMed ID: 2949797
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
    Toscano CF, Lahlou S.
    J Cardiovasc Pharmacol; 2003 Dec 06; 42(6):772-81. PubMed ID: 14639100
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF.
    J Pharmacol Exp Ther; 1984 Mar 06; 228(3):779-91. PubMed ID: 6707926
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555).
    Yang RH, Igarashi Y, Wyss JM, Chen YF.
    Brain Res Bull; 1990 Jan 06; 24(1):97-103. PubMed ID: 2138045
    [Abstract] [Full Text] [Related]

  • 11. Prolonged central effects of quinpirole on cardiovascular regulation.
    van den Buuse M, Morton SJ, Cornish JL, Head GA.
    J Pharmacol Exp Ther; 1996 Apr 06; 277(1):473-83. PubMed ID: 8613956
    [Abstract] [Full Text] [Related]

  • 12. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C, Haywood JR.
    J Pharmacol Exp Ther; 1986 Aug 06; 238(2):492-6. PubMed ID: 2874211
    [Abstract] [Full Text] [Related]

  • 13. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P, Becker H, Dietrich R, Luft F, Unger T.
    J Cardiovasc Pharmacol; 1986 Aug 06; 8(4):689-96. PubMed ID: 2427805
    [Abstract] [Full Text] [Related]

  • 14. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
    Hahn RA, MacDonald BR.
    J Pharmacol Exp Ther; 1984 Apr 06; 229(1):132-8. PubMed ID: 6707929
    [Abstract] [Full Text] [Related]

  • 15. Pressor responsiveness to intravenous quinpirole is blunted in malnourished, conscious rats: central vs. peripheral and spinal mechanisms.
    Lahlou S, Interaminense Lde F, Figueiredo AF, Duarte GP.
    J Cardiovasc Pharmacol; 2004 Jul 06; 44(1):16-25. PubMed ID: 15175553
    [Abstract] [Full Text] [Related]

  • 16. Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats.
    Kondo K, Suzuki H, Handa M, Nagahama S, Saruta T.
    Arch Int Pharmacodyn Ther; 1981 Apr 06; 250(2):273-8. PubMed ID: 7271387
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I, Lefèvre-Borg F, Gomeni R.
    J Pharmacol Exp Ther; 1981 Aug 06; 218(2):515-24. PubMed ID: 7252851
    [Abstract] [Full Text] [Related]

  • 18. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
    van den Buuse M.
    J Pharmacol Exp Ther; 1992 Jul 06; 262(1):303-11. PubMed ID: 1352551
    [Abstract] [Full Text] [Related]

  • 19. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S.
    Pharmacol Toxicol; 2001 May 06; 88(5):238-43. PubMed ID: 11393583
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S, Chen YF, Oparil S.
    J Pharmacol Exp Ther; 1984 Feb 06; 228(2):370-5. PubMed ID: 6363675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.